Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0454052
Funder
Australian Research Council
Funding Amount
$733,595.00
Summary
Tandem Matrix-Assisted Laser Desorption/Ionisation Time-Of-Flight Mass Spectrometer and Robots for High Throughput Proteomics Analysis. This proposal seeks to establish the capacity to perform high-energy tandem mass spectrometry on a high throughput basis, through purchase and coordinated operation of a Matrix-Assisted Laser Desorption/Ionisation - Time of Flight / Time of Flight - Mass Spectrometer and ancillary equipment, to enhance the proteomics expertise, infrastructure and research plans ....Tandem Matrix-Assisted Laser Desorption/Ionisation Time-Of-Flight Mass Spectrometer and Robots for High Throughput Proteomics Analysis. This proposal seeks to establish the capacity to perform high-energy tandem mass spectrometry on a high throughput basis, through purchase and coordinated operation of a Matrix-Assisted Laser Desorption/Ionisation - Time of Flight / Time of Flight - Mass Spectrometer and ancillary equipment, to enhance the proteomics expertise, infrastructure and research plans of a network of institutions from Queensland and New South Wales and their collaborators. Access to such instrumentation is critical to high level achievement in proteomics, a key platform technology for National Research Priorities relating to Frontier Technologies. No comparable instrument currently exists in Australia.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0561041
Funder
Australian Research Council
Funding Amount
$347,358.00
Summary
A New Generation Biosensor and Fluorescence Facility for Proteomics. The complete DNA sequence (the genome) is now known for many organisms and advances are being made to identify the complement of messenger RNA (the transcriptome) and the resultant collection of proteins (the proteome). The genome is largely fixed while the transcriptome and proteome differ between cell types in an organism and constantly vary to adapt the cell to changing conditions. The mediators of these variations are prote ....A New Generation Biosensor and Fluorescence Facility for Proteomics. The complete DNA sequence (the genome) is now known for many organisms and advances are being made to identify the complement of messenger RNA (the transcriptome) and the resultant collection of proteins (the proteome). The genome is largely fixed while the transcriptome and proteome differ between cell types in an organism and constantly vary to adapt the cell to changing conditions. The mediators of these variations are proteins, interacting with each other and with signal molecules. The next frontier in molecular biology is to identify and quantify these protein interactions. Our two institutions have a very large cohort of biologists whose research on proteins would be greatly facilitated by the Biacore 3000 and the ISS K2.Read moreRead less
Development of a topical treatment to replace surgical mulesing in sheep. 10,800 farms in Australia are sheep farms and a further 30,000 have sheep. Exports of wool earn over $2 billion annually. The animal rights campaign to ban mulesing has forced the industry to outlaw mulesing by 2010. Mulesing is largely confined to Australian Merino sheep and requires Australian research. If practical alternatives are not found costs will rise compromising the economic viability of many sheep farms. C ....Development of a topical treatment to replace surgical mulesing in sheep. 10,800 farms in Australia are sheep farms and a further 30,000 have sheep. Exports of wool earn over $2 billion annually. The animal rights campaign to ban mulesing has forced the industry to outlaw mulesing by 2010. Mulesing is largely confined to Australian Merino sheep and requires Australian research. If practical alternatives are not found costs will rise compromising the economic viability of many sheep farms. Chemical use on the breech will increase causing environmental contamination. A simple topical alternative to mulesing will allow farmers to economically manage flies and satisfy welfare imperatives. This will support rural communities and sustain Australia's export income from wool.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE100100030
Funder
Australian Research Council
Funding Amount
$1,200,000.00
Summary
Advanced focused ion beam (FIB) / scanning electron microscopes (SEM) for nanometre scale characterisation and fabrication. These instruments are designed to provide fundamental insights into physical and biological systems though characterisation and fabrication of structures at nanometre length scales. These versatile platforms will support a wide range of projects covering three national research priority areas. These range from the characterisation of light alloys for improving and building ....Advanced focused ion beam (FIB) / scanning electron microscopes (SEM) for nanometre scale characterisation and fabrication. These instruments are designed to provide fundamental insights into physical and biological systems though characterisation and fabrication of structures at nanometre length scales. These versatile platforms will support a wide range of projects covering three national research priority areas. These range from the characterisation of light alloys for improving and building Australia's Aluminium, Magnesium and Titanium alloy industries, to the study of aerosol particles for improved pulmonary drug delivery for asthma patients, the development of advanced solar cells and the study of the integrated behaviour of the soil-microbe system for sustainable agriculture.Read moreRead less
Biosynthesis of nonribosomal peptide toxins in cyanobacteria: A functional characterisation of microcystin synthetase. Microcystins are potent toxins and tumour promoters produced by cyanobacteria associated with blue-green algal blooms. This non-ribosomal peptide is produced by microcystin synthetase, a unique enzyme complex comprised of peptide synthetases, polyketide synthases, and integrated accessory enzymes. We have identified and characterised the extensive gene cluster encoding this enzy ....Biosynthesis of nonribosomal peptide toxins in cyanobacteria: A functional characterisation of microcystin synthetase. Microcystins are potent toxins and tumour promoters produced by cyanobacteria associated with blue-green algal blooms. This non-ribosomal peptide is produced by microcystin synthetase, a unique enzyme complex comprised of peptide synthetases, polyketide synthases, and integrated accessory enzymes. We have identified and characterised the extensive gene cluster encoding this enzyme. This project describes the biochemical characterisation of specific enzyme activities within microcystin synthetase and how they determine the final structure and toxicity of the many forms of microcystin. Interactions between this enzyme complex and its substrate amino acids will provide information for the genetic engineering of this and similar natural products.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0989946
Funder
Australian Research Council
Funding Amount
$357,000.00
Summary
High Resolution LC/MS and MALDI for Molecular and Macromolecular Characterisation. The provision of high-resolution and matrix assisted laser desorption ionisation mass spectrometers configured for the molecular and macromolecular research of high quality research groups will lead to earlier and better fundamental discoveries that are directed at important practical developments in medicine, biotechnology, nanotechnology, light-energy harvesting, polymer materials and sensors. These include anti ....High Resolution LC/MS and MALDI for Molecular and Macromolecular Characterisation. The provision of high-resolution and matrix assisted laser desorption ionisation mass spectrometers configured for the molecular and macromolecular research of high quality research groups will lead to earlier and better fundamental discoveries that are directed at important practical developments in medicine, biotechnology, nanotechnology, light-energy harvesting, polymer materials and sensors. These include anticancer agents, nanodevices for drug delivery, better polymers with more energy efficient industrial processes, bioactive molecules for industrially important nitrogen fixation and many more. Read moreRead less
Design of Polymeric Devices for Biotechnological Applications. The research project focuses on the development of functional polymer particles for diagnostic applications. Advanced polymer chemistry will be used to synthesize devices for reliable and fast diagnostic systems. The outcome of this work will help promoting and maintaining good health in Australia by developing novel technologies and advanced materials based on polymer science.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0668374
Funder
Australian Research Council
Funding Amount
$470,000.00
Summary
State-of-the-art NMR Facilities. This proposal will significantly enhance the NMR research capability and capacities at UoW and ANU. These schools have internationally recognised strengths in fundamentals of synthetic organic chemistry, therapeutic drug design and synthesis, protein chemistry and structural biology. This equipment will enhance the productivity of these researchers, increase their collaborative and scientific outputs and allow for training of students in the latest technologies ....State-of-the-art NMR Facilities. This proposal will significantly enhance the NMR research capability and capacities at UoW and ANU. These schools have internationally recognised strengths in fundamentals of synthetic organic chemistry, therapeutic drug design and synthesis, protein chemistry and structural biology. This equipment will enhance the productivity of these researchers, increase their collaborative and scientific outputs and allow for training of students in the latest technologies and importantly, contribute to Australia's development as a knowledge-based economy.Read moreRead less
Liver fluke: improving disease control through understanding of parasite diversity, drug resistance and better diagnosis. The benefits from this research include: (i) development of knowledge that will allow a better use of existing drug formulations to protect livestock from fasciolosis, potentially generating economic benefits to Australian producers of up to $50-80m/year; (ii) improved application of new commercial therapies for fasciolosis in ruminants, improving producer prosperity; (iii) ....Liver fluke: improving disease control through understanding of parasite diversity, drug resistance and better diagnosis. The benefits from this research include: (i) development of knowledge that will allow a better use of existing drug formulations to protect livestock from fasciolosis, potentially generating economic benefits to Australian producers of up to $50-80m/year; (ii) improved application of new commercial therapies for fasciolosis in ruminants, improving producer prosperity; (iii) enhanced training opportunities for graduate students that will build human capacity in technologies such as molecular diagnostics which have a wide application across the animal sectors; (iv) enhancement of our capacity to respond to unexpected future threats in production animals.Read moreRead less
Structure-based inhibitor design of VAP-1/SSAO for the treatment of respiratory dirsorders and other major inflammatory diseases. Inflammatory diseases, such as asthma, rheumatoid arthritis and multiple sclerosis, are widespread and often poorly treated in Australia and elsewhere. Inhibitors of the recently studied VAP-1/SSAO protein are predicted to effectively treat the inflammation symptoms of one or more of these diseases. A structure-based approach to discover these new medicines should pro ....Structure-based inhibitor design of VAP-1/SSAO for the treatment of respiratory dirsorders and other major inflammatory diseases. Inflammatory diseases, such as asthma, rheumatoid arthritis and multiple sclerosis, are widespread and often poorly treated in Australia and elsewhere. Inhibitors of the recently studied VAP-1/SSAO protein are predicted to effectively treat the inflammation symptoms of one or more of these diseases. A structure-based approach to discover these new medicines should provide a means to identify patentable compounds, with high potency, efficacy and safety. If this approach is successful, an Australian pharmaceutical company will be one of the first to the market with this new medicine to treat these chronic diseases.Read moreRead less